While there are more than a dozen species in the genus, the most troublesome species is Lonomia obliqua, and it is this species on which most of the medical research has centered. As anticoagulants have some very beneficial applications (e.g., prevention of life-threatening blood clots) the research is motivated by the possibility of deriving some pharmaceutically valuable chemicals from the toxin.